A Randomized Multicenter Double-Blind CT to Evaluate the Efficacy and Safety of Mycophenolate Mofetil . . . - Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00451867

Locations


United States, California
	Stanford University Medical center
	Stanford, California, United States, 94305
	Univeristy of California San Diego
	San Diego, California, United States, 92093

United States, Illinois
	Loyola University Medical Center
	Maywood, Illinois, United States, 60153

United States, Iowa
	University of Iowa
	Iowa City, Iowa, United States, 52242

United States, Maryland
	University of Maryland
	Baltimore, Maryland, United States, 21201

United States, Michigan
	William Beaumont Hospital
	Royal Oak, Michigan, United States, 48073
	Henry Ford Hospital
	Detroit, Michigan, United States, 48202

United States, New York
	University of Rochester
	Rochester, New York, United States, 14642

United States, Pennsylvania
	University of Pennsylvania Health System
	Philadelphia, Pennsylvania, United States, 19104

United States, Washington
	University of Washington
	Seattle, Washington, United States, 98195

Canada, Ontario
	Queen's University
	Kingston, Ontario, Canada, K7L2V7

Sponsors and Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Investigators


Study Director:	John Kusek, PhD	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Study Director:	LeRoy Nyberg, MD, PhD	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Principal Investigator:	Richard Landis, PhD	University of Pennsylnania

Study Chair:	David Burks, MD	Henry Ford Hospital

Principal Investigator:	Harris Foster, MD	Yale University